ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.567
0.002 (0.13%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.002 0.13% 1.567 1.536 1.598 1.55 1.538 1.55 4,833,427 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.40 17.59M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.59 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.40.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 9726 to 9748 of 13425 messages
Chat Pages: Latest  393  392  391  390  389  388  387  386  385  384  383  382  Older
DateSubjectAuthorDiscuss
15/6/2021
13:56
I think people are starting to cotton on to the fact the six product pipeline could be very valuable and has an unusually good spread of risk This quote really got my attention:"The Company's technology has the potential to enable many more patients suffering from devastating blood diseases such as leukemia and lymphoma, as well as severe autoimmune diseases such as multiple sclerosis, aplastic anemia and systemic lupus erythematosus (Lupus), to benefit from bone marrow transplantation."That alone is five really big markets.
idriveajag
15/6/2021
13:53
It doesn’t need loads of cash in the next 12-18m Badger. Settle down. And by the time next raise comes the share price will be much higher.

Which do you think will come first?

- buddy up with Eli on CDX through trials
- CAR T IND app
- CBR update on Biodefense or either of the 2 candidates being worked on?
- J&J collab concludes on lupus with a candidate?

I acknowledge how you steer away from the good things they’re unavoidably doing in the labs to focus on what you perceive to be their weakness currently.

The things is they’ve got cash for a good while now to tick off some big milestones and up the share price

Thems the facts

chimpychops81
15/6/2021
13:18
Our resident deramper badger60 is really getting desperate literally clutching at straws! What a sad character.
tonytony4
15/6/2021
13:05
Obviously doesn't like hearing the way it really is....... that's why she won't let me post there
badger60
15/6/2021
13:03
Seems like 'smell' next door is getting a bit jittery....
badger60
15/6/2021
12:51
DENMARKRNS is totally inconsequential.
badger60
15/6/2021
12:49
Explain "They already have".
badger60
15/6/2021
12:48
They already have. Grow up Badger :)
justaman
15/6/2021
12:46
....and as it stands with MadVlads abysmal track record, he'll be lucky to raise 2mio, probably a lot less, in house.
badger60
15/6/2021
12:46
interesting an rns re: agm rearrangement!
demark
15/6/2021
12:42
nearly 700m traded since
1 june (10.5 trading days)!
that is 72% of the issued
capital,
surely someone knows something!!

demark
15/6/2021
12:40
The huge problem that Hemocasino faces is that it's going to need significant amounts of money going forward (hence the failed 60mio CLN). The only way that this is going to happen is via a big pharma sponsor, as Hemocasino is totally incapable of raising such amounts itself.. especially with MadVlad driving the corporate bus.So....with one strike out already on CDX, I can't see a queue of big pharmas willing to chuck 10's if not 100's of mios MadVlads way on unproven IP which is all still preclinical.
badger60
15/6/2021
12:15
450k made me happy....
badger60
15/6/2021
12:02
So you claim, bit like everything else, I suspected you're a bit deluded but whatever makes you happy Badger.
justaman
15/6/2021
12:01
JustawomanBut a tool that printed 450k on Hemocasino last year...
badger60
15/6/2021
11:58
DENMARK50/50 on that one...,depends on where it's priced in relation to the sp, that's if my view on a new issue is correct. It also depends on who gets the shares.... if it's a give away private placement and shareholders are not included it will cause mayhem.
badger60
15/6/2021
11:48
badger60,
do you believe investors might
stump up for another fundraise
within 6mths from the last one?


badger6015 Jun '21 - 11:07 - 6007 of 6009
0 0 0
Much of Hemocasino's "10mio" has already been committed to ongoing and current expenses...IND, CDX license, Penn work and big pharma work on CDX, Orgenesis loan repayment etc., so available cash is, imo, circa 1 Mio. That's why I think that the current pump is a precursor to a new share issuance....those involved may well be going short as they know what they will be getting.

demark
15/6/2021
11:44
Yes anything bad about KEFI is very welcome with me. I sold because they going to lose their licenses in eithopia soon. As it seems that way from what I researched.
luckyabbeygale
15/6/2021
11:26
Such a tool
justaman
15/6/2021
11:21
KEFI has more gold in the ground that Fort Knox has gold painted lead bars.
badger60
15/6/2021
11:14
AbbyKEFI has inherently been a dog with fleas....the others I don't know about.
badger60
15/6/2021
11:07
Much of Hemocasino's "10mio" has already been committed to ongoing and current expenses...IND, CDX license, Penn work and big pharma work on CDX, Orgenesis loan repayment etc., so available cash is, imo, circa 1 Mio. That's why I think that the current pump is a precursor to a new share issuance....those involved may well be going short as they know what they will be getting.
badger60
15/6/2021
10:54
ZPHR should be going back down on profit taking. The company is spending far too much cash on acquisitions. I really messed up on that one. Especially after selling out after knowing about 3 institutions investing. It was panicking into KEFI that made me do that, and I ended up taking a loss on KEFI. The ones I bought with the KEFI money was IRON, HEMO and VELA. Which was at least some compensation.
luckyabbeygale
Chat Pages: Latest  393  392  391  390  389  388  387  386  385  384  383  382  Older

Your Recent History

Delayed Upgrade Clock